Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
110,429,984
-
Shares change
-
+19,218,637
-
Total reported value, excl. options
-
$3,390,723,363
-
Value change
-
+$589,807,191
-
Put/Call ratio
-
13.86%
-
Number of buys
-
83
-
Number of sells
-
-37
-
Price
-
$30.71
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q4 2021
157 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 110,429,984 shares
of 171,717,172 outstanding shares and own 64.31% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), FMR LLC (16,206,601 shares), VANGUARD GROUP INC (6,198,442 shares), BlackRock Inc. (5,993,613 shares), PRICE T ROWE ASSOCIATES INC /MD/ (4,155,341 shares), Bellevue Group AG (4,105,962 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (4,034,356 shares), Casdin Capital, LLC (3,857,253 shares), JPMORGAN CHASE & CO (3,367,312 shares), and STATE STREET CORP (3,186,522 shares).
This table shows the top 126 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.